CYP26B1
protein-codingcytochrome P450 family 26 subfamily B member 1, the group of Cytochrome P450 family 26
Gene summary
This gene encodes a member of the cytochrome P450 superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein is localized to the endoplasmic reticulum, and functions as a critical regulator of all-trans retinoic acid levels by the specific inactivation of all-trans retinoic acid to hydroxylated forms. Mutations in this gene are associated with radiohumeral fusions and other skeletal and craniofacial anomalies, and increased levels of the encoded protein are associated with atherosclerotic lesions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~18.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013740
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013740
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013740
Submitter: ClinGen
*CYP26B1* was first reported in relation to autosomal recessive lethal occipital encephalocele-skeletal dysplasia syndrome in 2011 (Laue et al., PMID: 22019272). This condition is often associated with intrauterine fetal demise, stillbirth, or neonatal death. However, probands may survive into adolescence or adulthood. Features of this condition include craniosynostosis (such as coronal, lambdoid, or sagittal); facial anomalies (like midface retrusion, frontal bossing, brachycephaly, and small ears); delayed ossification; digit anomalies (like oligodactyly or long/slender fingers and toes); narrow thorax; radiohumeral fusions; hearing loss; and respiratory issues. Nine variants (missense, splicing) that have been reported in at least seven probands in four publications (PMIDs: 22019272, 27410456, 34160123, 37755482) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function (PMID: 22019272). This gene-disease relationship is also supported by experimental evidence (mouse and zebrafish models; PMIDs: 15030763, 22019272). Mouse and zebrafish models show that CYP26B1 deficiency leads to skeletal anomalies like short limbs and inappropriate joint fusion; improper skeletal patterning during development; reduced body size; and craniosynostosis. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 2/19/2026 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0013740
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CYP26B1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_019885.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 31 | 7 | 38 | |||
| missense | 2 | 3 | 89 | 13 | 2 | 109 |
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 4 | 4 | 92 | 44 | 9 | 153 |
Highest pathogenic variant AF is 0.000004117768
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_063938.1 | 6 | MANE Select | |
| Ensembl | ENSP00000001146.2 | 6 | MANE Select | |
| RefSeq | NP_001264671.1 | 5 | Standard | |
| Ensembl | ENSP00000401465.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cyp26b1 | Danio rerio | Structure: osteoblast Quality: star shaped abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retinol metabolism - Homo sapiens (human)
- Adipogenesis
- Oxidation by Cytochrome P450
- Metapathway biotransformation Phase I and II
- Vitamin A and Carotenoid Metabolism
Biological Process
- cell fate determination
- establishment of T cell polarity
- kidney development
- vitamin metabolic process
- xenobiotic metabolic process
Molecular Function
- retinoic acid binding
- iron ion binding
- retinoic acid 4-hydroxylase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
- heme binding
Cellular Component
- cytoplasm
- endoplasmic reticulum membrane
- organelle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000001146
- Coding exons
- 6
- Length
- 18801
- Individuals with no LoFs
- 125667
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 78
- Defined
- 125745
- p
- 0.000310
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.05 | 275 | 329 | 0.837 | 0.0000219 | 3299 |
| Missense (PolyPhen) | 79 | 136.7 | 0.57792 | 1322 | ||
| Synonymous | -0.663 | 161 | 151 | 1.07 | 0.0000102 | 1070 |
| Loss of Function | 3.52 | 1 | 16.3 | 0.0612 | 7.11e-7 | 191 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00069 | 0.00068 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00083 | 0.00082 | rare |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00038 | 0.00036 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the metabolism of retinoic acid (RA), rendering this classical morphogen inactive through oxidation. Involved in the specific inactivation of all-trans-retinoic acid (all-trans-RA), with a preference for the following substrates: all-trans-RA > 9-cis-RA > 13-cis-RA. Generates several hydroxylated forms of RA, including 4-OH-RA, 4-oxo-RA, and 18-OH- RA. Essential for postnatal survival. Plays a central role in germ cell development: acts by degrading RA in the developing testis, preventing STRA8 expression, thereby leading to delay of meiosis. Required for the maintenance of the undifferentiated state of male germ cells during embryonic development in Sertoli cells, inducing arrest in G0 phase of the cell cycle and preventing meiotic entry. Plays a role in skeletal development, both at the level of patterning and in the ossification of bone and the establishment of some synovial joints. {ECO:0000269|PubMed:10823918, ECO:0000269|PubMed:22019272}.;
- Disease
- DISEASE: Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA) [MIM:614416]: A disease characterized by craniofacial malformations, occipital encephalocele, radiohumeral fusions, oligodactyly, advanced osseous maturation, and calvarial mineralization defects. {ECO:0000269|PubMed:22019272}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.151
Intolerance Scores
- LoFtool
- 0.462
- RVIS EVS
- 0
- RVIS percentile EVS
- 54.03
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.363
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |